SCHEMBL332719

SCHEMBL332719

CCC(C)B(C(C)CC)C(C)CC

nearest known ligand 0.38

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL476435 0.96 TSHR (0.35) TSHR
Ammonia Solution, Strong SCHEMBL19874799 0.96 TSHR (0.35) TSHR
SCHEMBL6563690 0.96 TSHR (0.35) TSHR
SCHEMBL43618 0.96 TSHR (0.35) TSHR
SCHEMBL312679 0.96 TSHR (0.35) TSHR
SCHEMBL10535072 0.96 TSHR (0.35) TSHR
SCHEMBL1800340 0.93 TSHR (0.33) TSHR
Water SCHEMBL2717905 0.93 TSHR (0.33) TSHR
Lithium Ion SCHEMBL22445007 0.93 TSHR (0.33) TSHR
Potassium Ion SCHEMBL952692 0.93 TSHR (0.33) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1134 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12612490-B2 Method for sequence controllable block copolymerization of cyclic ester and epoxy monomers SOUTH CHINA UNIVERSITY OF TECHNOLOGY (CN) 2026-04-28 US claimed
US-12486286-B2 Process and polymorphic forms of bictegravir and its pharmaceutically acceptable salts or co-crystals thereof LAURUS LABS LIMITED (IN) 2025-12-02 US claimed
CN-120025542-A Non-isocyanate polyurethane and multicomponent selective synthesis method thereof 华南理工大学 2025-05-23 CN claimed
CN-119978387-A Three-component synthesis method of polyphosphonate 华南理工大学 2025-05-13 CN claimed
CN-119978339-A Catalytic system for enhancing Lewis acid-base pair and application thereof 河北工业大学 2025-05-13 CN claimed
CN-119978342-A Nonmetal catalyst catalyzed high molecular weight CO2Base degradable plastic and preparation method thereof 浙江浙能科技环保集团股份有限公司 2025-05-13 CN claimed
CN-119978371-A Degradable aliphatic polysulfone synthesis method and polymer based on free radical rearrangement reaction 上海交通大学 2025-05-13 CN claimed
CN-119613701-A Method for synthesizing functionalized polyether in multi-proton system 华南理工大学 2025-03-14 CN claimed
CN-119350623-A Molecular weight controllable fluorosilicone rubber and preparation method thereof 中国科学院大连化学物理研究所 2025-01-24 CN claimed
CN-118955886-A Carbonate functionalized polymer and synthetic method and application thereof 华南理工大学 2024-11-15 CN claimed
US-5225608-A Reacting acetoacetic ester with 4-methyl-4-methoxypentanal in presence of secondary amine, decarboxylating in presence of hydroxide, reducing to substituted cyclohexanol BASF K & F CORPORATION (US) 1993-07-06 US claimed
US-5098876-A A molybdenum-rhenium oxide catalyst with an organoboron promoter for disproportionation reactions SHELL OIL COMPANY (US) 1992-03-24 US claimed
WO-1991016316-A1 PROCESS FOR PREPARING ISOXAZOLINES BP CHEMICALS LIMITED (GB) 1991-10-31 WO claimed
EP-0453189-A1 Process for preparing isoxazolines von Oppolzer, Wolfgang Wilhelm R.E.J. (CH) 1991-10-23 EP claimed
WO-1991015858-A1 METHODS AND AGENTS FOR DEUTERIUM/TRITIUM LABELING THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1991-10-17 WO claimed
US-5057644-A Catalytic ethylation SHELL OIL COMPANY (US) 1991-10-15 US claimed
EP-0241200-B1 PROCESS FOR PRODUCING 1-BETAMETHYLCARBAPENEM ANTIBIOTIC INTERMEDIATES MERCK & CO. INC. (US) 1990-12-27 EP claimed
EP-0123535-B1 NEW PHENYLALKANOIC ACID DERIVATIVES, THEIR PREPARATION AND USE SANKYO COMPANY LIMITED (JP) 1986-07-23 EP claimed
EP-0123535-A1 New phenylalkanoic acid derivatives, their preparation and use SANKYO COMPANY LIMITED (JP) 1984-10-31 EP claimed
US-4464480-A Method for obtaining improved catalyst systems UOP INC. (US) 1984-08-07 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12612490-B2 Method for sequence controllable block copolymerization of cyclic ester and epoxy monomers ELL, GNE, EPHX2 TSHR 868/4885
US-12486286-B2 Process and polymorphic forms of bictegravir and its pharmaceutically acceptable salts or co-crystals thereof CYP3A43, CYP3A5, CYP3A4 TSHR 4875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.